Qualitative and Quantitative Analysis of Dioxins in Polycarbonate (PC) Materials

Dioxins (PCDDs and PCDFs) are among the most toxic persistent organic pollutants, and trace-level testing of polycarbonate (PC) materials is increasingly required for regulatory compliance, green procurement, and food-contact safety. This technical article explains the qualitative and quantitative analysis of dioxins in PC resins and finished products, covering sample preparation, cleanup, HRGC/HRMS identification criteria, TEQ calculation, applicable standards, and typical industrial applications.

Technical Overview

Polychlorinated dibenzo-p-dioxins (PCDDs) and polychlorinated dibenzofurans (PCDFs), collectively known as dioxins, are a family of 210 chlorinated tricyclic aromatic compounds recognized as persistent organic pollutants (POPs). Among them, only the seventeen congeners substituted at all four 2,3,7,8 positions are considered toxicologically significant, with 2,3,7,8-tetrachlorodibenzo-p-dioxin (2,3,7,8-TCDD) being the most potent. Because individual congeners differ greatly in toxicity, results are conventionally expressed as toxic equivalents (TEQ), calculated by multiplying the mass concentration of each congener by its WHO toxic equivalency factor (TEF).

Although polycarbonate (PC) itself is a chlorine-free polymer, trace dioxin contamination can arise from the interfacial polycondensation process, which uses phosgene and chlorinated solvents, from chlorinated processing aids, or from post-consumer recyclate contaminated with chlorinated or brominated flame retardants that can form PCDD/F precursors during thermal reprocessing. Consequently, PC materials used in food-contact articles, medical devices, electronics, toys, and applications governed by halogen-free specifications are frequently subject to dioxin screening and confirmatory testing at picogram-per-gram (ppt) levels.

• Stockholm Convention on POPs: PCDD/Fs are listed as unintentionally produced POPs (Annex C).
• EU POPs Regulation (EU) 2019/1021: controls unintentional trace contaminants in substances, mixtures, and articles.
• Food-contact and contaminant frameworks such as Commission Regulation (EU) 2023/915 for PCDD/F and dioxin-like PCB limits in foodstuffs.
• Customer and industry specifications, including halogen-free requirements aligned with IEC 61249-2-21 and green procurement programs.

Testing Samples

Virgin PC Resins and Pellets

Base polymer granules from polymerization lines are tested to verify that upstream synthesis, solvent recovery, and finishing operations have not introduced chlorinated aromatic by-products. Homogeneous pellet lots are typically cryogenically milled to improve extraction efficiency.

PC Finished Products and Components

Injection-molded parts, extruded films and sheets, optical media substrates, lighting diffusers, lenses, transparent covers, and equipment housings can be tested as delivered, after cutting and milling to a defined particle size.

PC Blends and Alloys

PC/ABS, PC/PBT, PC/PA, and glass- or mineral-filled PC compounds require dioxin testing because blending partners and additives may contribute halogenated impurities or catalyzed degradation products.

Recycled PC and Regrind Materials

Post-industrial and post-consumer recyclates carry the highest contamination risk, particularly when mixed plastic streams contain brominated flame retardants or PVC residues. Testing supports recyclate certification and demonstrates compliance with low-POP-content thresholds.

PC Food Contact and Medical Articles

Reusable bottles, water dispenser components, infant products, infusion set parts, and dialyzer housings are tested to support safety assessments and regulatory dossiers where trace dioxin limits may apply.

Testing Items

The core analytical scope covers the seventeen toxic 2,3,7,8-substituted PCDD/F congeners, with optional extension to the twelve dioxin-like PCBs for a combined WHO-PCB-TEQ. Reported parameters include individual congener concentrations, homologue group totals, total PCDD/F mass, and the summed WHO-TEQ.

• PCDD congeners: 2,3,7,8-TCDD; 1,2,3,7,8-PeCDD; 1,2,3,4,7,8-HxCDD; 1,2,3,6,7,8-HxCDD; 1,2,3,7,8,9-HxCDD; 1,2,3,4,6,7,8-HpCDD; OCDD.
• PCDF congeners: 2,3,7,8-TCDF; 1,2,3,7,8-PeCDF; 2,3,4,7,8-PeCDF; 1,2,3,4,7,8-HxCDF; 1,2,3,6,7,8-HxCDF; 1,2,3,7,8,9-HxCDF; 2,3,4,6,7,8-HxCDF; 1,2,3,4,6,7,8-HpCDF; 1,2,3,4,7,8,9-HpCDF; OCDF.
• Optional dioxin-like PCBs (non-ortho PCB-77, PCB-81, PCB-126, PCB-169 and eight mono-ortho congeners).
• Calculated results: total PCDD/F (ng/kg or pg/g), lower-bound and upper-bound WHO-TEQ, and congener fingerprint profiles for source identification.

Testing Methods

Sample Pretreatment and Extraction

Representative samples (typically 2–20 g, depending on the required detection limit) are cryogenically milled to below 1 mm, weighed, and spiked with a full suite of carbon-13 labeled internal standards before extraction. Extraction is performed by accelerated solvent extraction (ASE) at elevated temperature and pressure, prolonged Soxhlet extraction with toluene, or validated ultrasonic extraction, ensuring quantitative recovery of the tightly bound planar congeners from the polymer matrix.

Cleanup and Fractionation

Crude extracts are concentrated and passed through a multi-stage cleanup train conventionally comprising multilayer silica gel (acidic, basic, and neutral), neutral alumina, and activated carbon or florisil columns. The carbon column selectively retains planar PCDD/Fs and non-ortho PCBs, which are subsequently back-eluted, isolating the dioxin fraction from pigments, plastic additives, oligomers, and other matrix interferences.

HRGC/HRMS Determination

The confirmatory method is isotope dilution high-resolution gas chromatography coupled with high-resolution mass spectrometry (HRGC/HRMS) in electron ionization SIM mode, following EPA Method 1613B or equivalent protocols (EPA 8290A, EN 1948, JIS K 0311, ISO 18073, adapted to polymer matrices). A 60 m low-bleed column such as DB-5MS, complemented by a DB-225 or equivalent column for confirmatory separation of 2,3,4,7,8-HxCDF isomers, is coupled to a double-focusing magnetic sector MS operated at a resolving power of at least 10,000 (10% valley), monitoring the two most intense exact masses of the molecular ion cluster (M and M+2) for each congener and its labeled analog.

Qualitative Identification Criteria

A congener is positively identified only when all of the following criteria are satisfied simultaneously:

• Retention time of both monitored ion maxima coincides within approximately ±3 seconds of the corresponding carbon-13 labeled standard.
• Simultaneous detection of both characteristic ions with a signal-to-noise ratio of at least 3 at the correct retention time.
• The relative abundance (ion ratio) of the two quantitation/confirmation ions falls within ±15% of the theoretical chlorine isotope ratio.
• The labeled analog is present at the expected retention time with acceptable recovery, and no significant peaks appear in the method blank.

Quantification and TEQ Calculation

Quantification uses the isotope dilution principle: congener concentrations are calculated from multipoint relative response factor calibration established with five or more calibration levels and verified with continuing calibration checks. The final result is the sum of each congener mass multiplied by its WHO 2005 TEF, reported as pg WHO-TEQ/g; typical TEF values include 1 for 2,3,7,8-TCDD, 0.1 for HxCDD/HxCDF groups, 0.01 for HpCDD/HpCDF, and 0.0003 for OCDD/OCDF. Reporting should state whether upper-bound, medium-bound, or lower-bound conventions were applied and which TEF scheme was used, as the 2022 WHO re-evaluation has proposed revised TEFs for several congeners.

Screening and Alternative Techniques

For high-throughput screening, triple-quadrupole GC-MS/MS operated in MRM mode (for example, EN 16215-type methods) and effect-based bioassays such as DR-CALUX can pre-screen extracts rapidly and cost-effectively. Samples exceeding screening decision limits are then confirmed by HRGC/HRMS, which remains the internationally recognized reference technique for definitive dioxin determination.

Quality Assurance and Reporting

Each analytical batch includes a method blank, ongoing precision and recovery (OPR) spikes, calibration verification, and labeled-standard recovery checks against EPA 1613B acceptance windows, ensuring data quality under ISO/IEC 17025-accredited laboratory conditions. Typical reporting limits for PC matrices reach 0.01–0.1 pg/g per congener, with method TEQ detection capability on the order of 0.1 pg WHO-TEQ/g.

Applications

PC dioxin testing services support compliance, quality control, and research objectives across the polymer value chain:

• Regulatory compliance demonstrations for POPs legislation in the EU, China, and other export markets.
• Supplier qualification and incoming inspection of PC resins, additives, and recyclates for electronics and E&E products.
• Safety assessments for food-contact materials, infant products, and medical devices.
• Recycled-content verification and certification of post-consumer PC streams against low-POP-content criteria.
• Failure analysis and R&D studies, including thermal-degradation investigations and congener fingerprinting for source tracing.
• Third-party test reports for tenders, customer audits, and customs clearance.

FAQ

What sample size and form are required for testing?

Approximately 2–20 g of material is normally sufficient. Pellets, granules, or cut parts are acceptable, although cryogenic milling to a fine powder is recommended to guarantee representative and exhaustive extraction.

What detection limits can be achieved?

Using HRGC/HRMS with isotope dilution, reporting limits of roughly 0.01–0.1 pg/g per congener and a method TEQ limit on the order of 0.1 pg WHO-TEQ/g are routinely achievable for PC matrices, subject to blank performance.

How are non-detects treated in the TEQ result?

Consistent with international conventions, laboratories may report lower-bound (non-detects counted as zero), medium-bound (half of the limit), and upper-bound (limit) TEQ values; the convention applied must be clearly stated on the report.

Why is HRGC/HRMS preferred over ordinary GC-MS?

Dioxins must be measured at picogram levels in a chemically complex polymer matrix. The high resolving power (≥10,000) of sector MS eliminates isobaric interferences, while isotope dilution with carbon-13 standards corrects for recovery losses, delivering legally defensible qualitative and quantitative results.

Which test standards are applicable?

EPA 1613B is the primary reference method, with EPA 8290A, EN 1948, JIS K 0311, and ISO 18073 providing equivalent or complementary protocols; these are adapted and validated for solid polymer matrices by accredited laboratories.

How long does the analysis take?

Standard turnaround is typically 7–15 working days from sample receipt, depending on queue, matrix complexity, and whether confirmatory reanalysis or second-column verification of specific congeners is required.